Treatment, Management, and Building Your Care Team
At a Glance
Although no treatment currently stops Laurence-Moon syndrome, individualized care can support vision, mobility, hormone health, fertility goals, and safety. Regular monitoring, rehabilitation, appropriate hormone therapy, and a coordinated specialist team are central to care.
While there is currently no disease-modifying cure for Laurence-Moon syndrome, a proactive and symptom-directed approach can significantly improve your quality of life [1][2]. Because PNPLA6-related disorders affect multiple systems, your care will be highly individualized, focusing on the specific way the condition impacts your vision, movement, and hormones [3][4].
Managing Your Vision
Vision loss in Laurence-Moon syndrome is progressive. The goal of management is to track these changes closely and maximize your remaining vision [5][6].
- Comprehensive Monitoring: Standard care includes a “multimodal” assessment using tools like OCT (to see retinal layers), fundus autofluorescence (FAF) to check cell health, and visual field testing [5][4].
- Low-Vision Rehabilitation: Working with specialists in orientation and mobility (O&M) and low-vision therapy can provide you with practical tools. This includes high-powered magnifiers, safe navigation strategies for low light, assistive screen-reading technology, and guidance on driving or transportation alternatives [5].
Neurological and Mobility Support
Neurological symptoms like ataxia (balance issues) and spasticity (stiffness) require proactive management to help you maintain independence [1].
- Physical Therapy (PT): A specialized PT program focusing on balance, gait training, and regular stretching can help manage stiffness and reduce the risk of falls [7][1].
- Occupational Therapy (OT): An OT can assess your home for safety (fall-proofing) and recommend adaptive equipment, such as grab bars or specialized tools, to help you safely navigate your daily routine [7].
- Mobility Aids: Introducing aids like canes, walkers, or orthoses early can provide the stability needed to stay active and engaged in your community [1].
Endocrine and Hormone Care
Managing the hormonal impacts of PNPLA6 is essential for bone health, energy, and well-being, but it must be done carefully under an endocrinologist’s supervision. Never start or adjust hormone treatments on your own.
- Hormone Replacement for Health: For hypogonadotropic hypogonadism, doctors typically prescribe testosterone or estrogen/progesterone to induce puberty or maintain adult bone and hormone health [8][9]. Crucially, testosterone replacement can suppress sperm production and is NOT a fertility treatment.
- Fertility Planning: If you are trying to conceive, you must consult a reproductive endocrinologist, urologist, or fertility specialist. Fertility treatments involve entirely different medications (such as gonadotropins like FSH/hCG) tailored to your specific reproductive goals and anatomy [8][9].
- Growth and Adrenal Support: If testing confirms a growth hormone deficiency, recombinant growth hormone may be prescribed [10]. For patients diagnosed with adrenal insufficiency, your doctor will prescribe daily steroids and provide a strict “sick-day plan” (stress-dose steroids for illness or surgery), emergency hydrocortisone injections, and a recommendation to wear a medical-alert ID [11][10].
Building Your Multidisciplinary Team
Because this condition is rare and complex, you need a coordinated team of specialists. Your core team should include:
- Clinical Geneticist and Genetic Counselor: To coordinate testing and guide family planning [3].
- Neuro-ophthalmologist or Inherited Retinal Disease Specialist: To monitor and image your vision [5].
- Neurologist: To monitor balance, coordination, and nerve health over time [1].
- Endocrinologist: To manage pituitary hormone levels, and a reproductive endocrinologist if fertility is a goal [10][8].
- Physiatrist or Rehabilitation Team: To oversee physical and occupational therapy [7].
Talk to your genetics team about reputable rare-disease registries, patient organizations, or clinical research opportunities. While participation never guarantees a clinical benefit, staying connected to the research community ensures you are aware of emerging insights into the PNPLA6 spectrum [2].
Common questions in this guide
Is there a cure for Laurence-Moon syndrome?
How can progressive vision loss from Laurence-Moon syndrome be managed?
What support can help with balance and stiffness?
What hormone treatments may be needed for Laurence-Moon syndrome?
Is testosterone replacement a fertility treatment?
Which specialists should manage Laurence-Moon syndrome?
How can I find research or rare-disease registries for PNPLA6-related disorders?
Get notified when new evidence is published on Laurence-Moon syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Multifaceted and Age-Dependent Phenotypes Associated With Biallelic PNPLA6 Gene Variants: Eight Novel Cases and Review of the Literature.
Nanetti L, Di Bella D, Magri S, et al.
Frontiers in neurology 2021; (12()):793547 doi:10.3389/fneur.2021.793547.
PMID: 35069422 - 2
Neuropathy target esterase activity defines phenotypes among PNPLA6 disorders.
Liu J, He Y, Lwin C, et al.
Brain : a journal of neurology 2024; (147(6)):2085-2097 doi:10.1093/brain/awae055.
PMID: 38735647 - 3
PNPLA6 disorders: what's in a name?
Liu J, Hufnagel RB
Ophthalmic genetics 2023; (44(6)):530-538 doi:10.1080/13816810.2023.2254830.
PMID: 37732399 - 4
Novel variants in PNPLA6 causing syndromic retinal dystrophy.
Wu S, Sun Z, Zhu T, et al.
Experimental eye research 2021; (202()):108327 doi:10.1016/j.exer.2020.108327.
PMID: 33141049 - 5
Detailed retinal phenotype of Boucher-Neuhäuser syndrome associated with mutations in PNPLA6 mimicking choroideremia.
O'Neil E, Serrano L, Scoles D, et al.
Ophthalmic genetics 2019; (40(3)):267-275 doi:10.1080/13816810.2019.1605392.
PMID: 31135245 - 6
Oliver McFarlane syndrome: two new cases and a review of the literature.
Lisbjerg K, Andersen MKG, Bertelsen M, et al.
Ophthalmic genetics 2021; (42(4)):464-473 doi:10.1080/13816810.2021.1904419.
PMID: 33818269 - 7
Homozygous PNPLA6 Mutation (p.Arg1183Trp) Associated With Isolated Cerebellar Ataxia: A Familial Case Report.
Alawadhi A, Almarzooqi A, Khan M, Alrukn S
Cureus 2026; (18(4)):e107039 doi:10.7759/cureus.107039.
PMID: 42147656 - 8
Novel PNPLA6 Variants: Hypogonadotropic Hypogonadism, Pituitary Hypoplasia, Anosmia, and Cerebellar Atrophy in Siblings.
Hussain MA, Kumar V, Chapla A, et al.
JCEM case reports 2026; (4(1)):luaf286 doi:10.1210/jcemcr/luaf286.
PMID: 41356532 - 9
Fertility outcomes and management of long-term pubertal testosterone replacement sequelae in Oliver-McFarlane syndrome: a case report and literature review.
Moshe S, Dekel Y, Oron G, Kabha M
AME case reports 2026; (10()):116 doi:10.21037/acr-2026-0024.
PMID: 42299415 - 10
New insights into Oliver-McFarlane syndrome: adrenocortical hypofunction and variable expressivity in a Chinese sibling pair.
Du C, Yu T, Liu S, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(6)):622-627 doi:10.1515/jpem-2025-0731.
PMID: 41846525 - 11
Novel variant in PNPLA6 gene causes Oliver-McFarlane syndrome in a Chinese family: 13 years follow-up.
Xiao P, Gu Y, Qi X, et al.
Frontiers in genetics 2025; (16()):1693876 doi:10.3389/fgene.2025.1693876.
PMID: 41321566
This page describes treatment and care planning for Laurence-Moon syndrome for educational purposes only and does not replace medical advice. Discuss hormone, fertility, adrenal, vision, and mobility decisions with your specialist team.